LAX.SH
SYNGENE INTERNATIONAL LTD·CDMO 77.10BUSINESS SUPPORT 40.67·Healthcare Services Companies
Price
372.5
-1.05%52W Range
Market Cap
₹15,036.68 Cr
Traded: ₹16.72 Cr (0.11%) 0.0x
Free Float: ₹1,005.95 Cr (1.66% of FF traded)
Volume · 60D trend
4.49 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
RS Score
Create a free account to unlock your edge
Scanners, market pulse, FII/DII data, and TradingView charts — free forever
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| ROE | -- | +11.0% | +10.0% | -- | -- | Decelerating |
| Return | +9.0% | -3.0% | -12.0% | -26.0% | -- | Decelerating |
| Sales | -- | +11.0% | +5.0% | -- | +3.0% | Decelerating |
| Profit | -- | +0.0% | -7.0% | -- | -21.0% | Decelerating |
Quarterly Results
Mar 2023
Dec 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 736 | 1,037 | 917 | 911 | 875 | 1,018 | 944 | 891 | 790 | 917 | 854 | 910 | 808 | 994 | 786 |
| Expenses | 645 | 733 | 708 | 711 | 668 | 674 | 660 | 646 | 620 | 600 | 622 | 656 | 596 | 680 | 555 |
| Operating Profit | 91 | 303 | 209 | 200 | 206 | 344 | 284 | 245 | 170 | 317 | 232 | 254 | 212 | 314 | 231 |
| Other Income | 12 | 16 | -55 | 15 | 18 | 19 | 18 | 17 | 50 | 16 | 26 | 14 | 24 | 23 | 17 |
| Interest | 10 | 12 | 12 | 13 | 12 | 16 | 12 | 13 | 12 | 13 | 11 | 13 | 11 | 10 | 14 |
| Depreciation | 112 | 112 | 114 | 117 | 111 | 106 | 109 | 111 | 107 | 111 | 108 | 105 | 102 | 96 | 95 |
| Profit Before Tax | -19 | 196 | 28 | 85 | 101 | 241 | 181 | 137 | 101 | 209 | 138 | 151 | 123 | 231 | 140 |
| Tax % | -53.1% | 24.5% | 47.2% | 21.2% | 14.4% | 23.8% | 27.5% | 22.7% | 25.3% | 9.8% | 19.3% | 22.7% | 24.0% | 23.0% | 22.0% |
| Net Profit | -9 | 148 | 15 | 67 | 87 | 183 | 131 | 106 | 76 | 189 | 112 | 117 | 93 | 179 | 110 |
| Exceptional Items | -- | -6 | -71 | 0 | 0 | 0 | 0 | 0 | 32 | 0 | -4 | -7 | 0 | 0 | 0 |
| EPS (Rs) | -0.2 | 3.7 | 0.4 | 1.7 | 2.1 | 4.5 | 3.3 | 2.6 | 1.9 | 4.7 | 2.8 | 2.9 | 2.3 | 4.5 | 2.7 |
| Sales Growth (YoY) | -- | 1.8% | -2.8% | 2.2% | 10.7% | 11.0% | 10.6% | -2.1% | -2.3% | -7.8% | 8.6% | 18.5% | 25.4% | 31.2% | -- |
| Sales Growth (QoQ) | -- | 13.0% | 0.7% | 4.2% | -14.2% | 7.8% | 6.0% | 12.8% | -13.8% | 7.4% | -6.2% | 12.6% | -18.7% | 26.5% | -- |
| OP Growth (YoY) | -56.0% | -11.7% | -26.2% | -18.5% | 21.6% | 8.4% | 22.5% | -3.7% | -19.9% | 0.9% | 0.2% | -- | -- | -- | -- |
| OP Growth (QoQ) | -70.1% | 45.0% | 4.9% | -3.3% | -39.9% | 21.2% | 15.8% | 44.2% | -46.4% | 36.9% | -8.9% | 19.9% | -32.5% | 35.9% | -- |
| Profit Growth (YoY) | -- | -17.0% | -45.0% | -37.0% | 67.0% | -3.0% | 15.0% | -13.0% | -45.0% | 6.0% | 4.0% | 20.0% | 26.0% | 21.0% | 5.0% |
| EPS Growth (YoY) | -- | -19.3% | -88.7% | -36.7% | 14.4% | -3.0% | 17.7% | -9.0% | -19.0% | 5.4% | 1.5% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -- | 891.9% | -77.8% | -22.3% | -52.8% | 39.6% | 23.5% | 40.4% | -59.9% | 69.3% | -4.5% | 25.0% | -47.9% | 63.0% | -- |
| OP Margin | -- | 29.3% | 22.8% | 21.9% | 23.6% | 33.8% | 30.1% | 27.5% | 21.5% | 34.6% | 27.2% | 27.9% | 26.2% | 31.6% | 29.4% |
| Net Margin | -- | 14.3% | 1.6% | 7.3% | 9.9% | 18.0% | 13.9% | 11.9% | 9.6% | 20.6% | 13.1% | 12.8% | 11.5% | 18.0% | 14.0% |
| Material Cost % | -- | 22.5% | 25.0% | 26.2% | 24.9% | 23.1% | 25.2% | 26.6% | 29.6% | 22.1% | 27.8% | 29.4% | 27.6% | 29.6% | 26.2% |
| Employee Cost % | -- | 29.0% | 29.2% | 30.2% | 29.9% | 24.9% | 26.4% | 28.2% | 29.1% | 24.8% | 25.9% | 24.8% | 26.7% | 23.9% | 26.8% |
| P/S | 4.18 | 4.47 | 4.68 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 67.85 | 52.70 | 49.45 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 3.11 | 3.46 | 3.68 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Intimation of Conference Call for Analysts and Investors
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018.
Syngene International Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2026 ,inter alia, to consider and approve the Un-Audited Standalone ....
Resignation of Mr. Pramuch Goel as Head Corporate Affairs & Communications and a member of Executive Committee (Senior Management Personnel) of the Company w.e.f. the close of business ....
Intimation of Schedule of Meeting with Analyst/Institutional Investor
Intimation of Schedule of Meeting with Analyst/Institutional Investor
Intimation of Schedule of Meeting with Analyst/Institutional Investor
Communication regarding remittance of final dividend for the FY 2025-26
Grant of Performance Share Units under Syngene Long Term Incentive Performance Share Plan (PSP) 2023 ("Plan")
Intimation of Schedule of Investor/Analyst Meeting with Goldman Sachs Asia Leaders Conference 2026
Intimation of investment in Ampin C&I Power Twelve Private Limited
Intimation of Investor call schedule with Entrust Family Office
Intimation of Schedule of Meeting with Analyst/Institutional Investor on August 13, 2026 and August 14, 2026.
Intimation of Earnings Conference call transcript for Q1 FY2027
Scrutinizer''s Report and voting results of 33rd Annual General Meeting
Results - Financial Results for quarter ended June 30, 2026
Proceedings of the 33rd Annual General Meeting
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mirae Asset Mutual Fund
Intimation of Conference Call with Analysts and Investors.
Change in Senior Managerial Personnel
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.
Syngene International Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2026 ,inter alia, to consider and approve the un-audited Standalone ....
Resignation of Statutory Auditor of material subsidiary
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Newspaper Advertisement - Notice of the 33rd Annual General Meeting ("AGM") and Annual Report for FY 2025-26.
Intimation of Resignation letter of Mr. Peter Bains in terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations")
Notice of 33rd Annual General Meeting ('AGM') and Annual Report for FY 2025-26
Notice of 33rd Annual General Meeting ("AGM") scheduled on Wednesday, July 29, 2026.
Press Release
Newspaper Advertisement - Intimation of date of the 33rd Annual General Meeting, Record date and Final dividend information.
Intimation of Closure of Trading Window
Email communication to Shareholders - TDS on Final Dividend
Postal Ballot - Outcome
Postal Ballot - Scrutinizer''s Report
Intimation of Schedule of Meeting with Analyst/Institutional Investor on June 19, 2026.
Intimation of Schedule of Meeting with Analyst/Institutional Investor(s) on June 10, 2026 and June 11, 2026.
Newspaper Advertisement - Notice of transfer of equity shares to Investor Education and Protection Fund
Reminder letter to the Shareholders for claiming Unclaimed Dividends and updation of KYC Information.
Newspaper Publication - Notice of Postal Ballot and cut-off date
Intimation of Postal Ballot and Cut-off date
Annual Secretarial Compliance Report for the financial year ended March 31, 2026
Outcome of Board Meeting - Voluntary liquidation of Syngene Manufacturing Solutions Limited, a Wholly Owned Subsidiary.
Intimation of Earnings call transcript for Q4 FY2026
Advertisement in Newspapers - Financial Results
Intimation of audio recording for Q4 FY26 post-earnings call
Investor Presentation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Syngene International Limited has informed the Exchange that Record date for the purpose of Dividend is June 26, 2026.
Intimation of change in Key Managerial Personnel (KMP) to determine Materiality of an event or information.
Regulation 30 - Appointment of Statutory Auditors
Reg 30 - Change in Management
Annual Reports
11Credit Ratings
6Concalls
49Jan 2026
31 Jan 2026Nov 2025
30 Nov 2025Sep 2025
30 Sept 2025Jul 2025
31 Jul 2025Apr 2025
30 Apr 2025Mar 2025
31 Mar 2025Jan 2025
31 Jan 2025Oct 2024
31 Oct 2024Jul 2024
31 Jul 2024Jul 2024
31 Jul 2024Apr 2024
30 Apr 2024Jan 2024
31 Jan 2024Jan 2024
31 Jan 2024Oct 2023
31 Oct 2023Jul 2023
31 Jul 2023May 2023
31 May 2023Jan 2023
31 Jan 2023Oct 2022
31 Oct 2022Jul 2022
31 Jul 2022Apr 2022
30 Apr 2022Jan 2022
31 Jan 2022Oct 2021
31 Oct 2021Jul 2021
31 Jul 2021Apr 2021
30 Apr 2021Mar 2021
31 Mar 2021Jan 2021
31 Jan 2021Oct 2020
31 Oct 2020Jul 2020
31 Jul 2020May 2020
31 May 2020Feb 2020
29 Feb 2020Jan 2020
31 Jan 2020Dec 2019
31 Dec 2019Oct 2019
31 Oct 2019Jul 2019
31 Jul 2019Apr 2019
30 Apr 2019Feb 2019
28 Feb 2019Oct 2018
31 Oct 2018Jul 2018
31 Jul 2018May 2018
31 May 2018Apr 2018
30 Apr 2018Jan 2018
31 Jan 2018Nov 2017
30 Nov 2017Aug 2017
31 Aug 2017May 2017
31 May 2017Jan 2017
31 Jan 2017Oct 2016
31 Oct 2016Jul 2016
31 Jul 2016Feb 2016
29 Feb 2016Oct 2015
31 Oct 2015Held by ETFs
19 ETFs hold syngene · sorted by weight
Held by Mutual Funds
71 schemes hold syngene · sorted by weight